Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	36.47	48	72.9	76.68	108.91	77.83
Cash & Short-Term Investments	36.47	48	72.9	76.68	108.91	77.83
Cash Growth	-39.14%	-34.16%	-4.92%	-29.60%	39.93%	22.45%
Other Current Assets	1.27	1.38	1.6	1.59	2.03	1.92
Total Current Assets	37.74	49.38	74.51	78.26	110.94	79.75
Net Property, Plant & Equipment	2.08	2.06	2.07	2.87	2.95	0.64
Other Long-Term Assets	0.34	0.34	0.32	0.31	0.3	-
Total Assets	40.16	51.78	76.9	81.45	114.19	80.39

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.51	7.25	7.57	7.95	10.13	5.54
Current Portion of Leases	0.75	0.72	0.58	0.54	0.5	0.31
Unearned Revenue	-	-	-	-	-	1
Total Current Liabilities	9.26	7.97	8.15	8.49	10.63	6.84
Long-Term Leases	0.6	0.97	0.99	1.57	2.08	0
Other Long-Term Liabilities	-	35	35	35	35	-
Total Long-Term Liabilities	0.6	35.97	35.99	36.57	37.08	0
Total Liabilities	9.86	43.94	44.14	45.07	47.71	6.84

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.03	0.03	0.03	0.03	0.03	0.02
Additional Paid-in Capital	417.67	417.54	408.55	373.93	355.22	329.27
Accumulated Other Comprehensive Income	-0.06	-0.02	-	-	-	-
Retained Earnings	-387.33	-409.71	-375.83	-337.58	-288.77	-255.75
Shareholders' Equity	30.3	7.83	32.76	36.38	66.48	73.55
Total Liabilities & Equity	40.16	51.78	76.9	81.45	114.19	80.39

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.34	1.69	1.57	2.11	2.58	0.31
Net Cash (Debt)	35.13	46.3	71.33	74.56	106.33	77.52
Net Cash Growth	-40.09%	-35.09%	-4.34%	-29.87%	37.16%	23.39%
Net Cash Per Share	1.12	1.48	2.37	2.80	4.40	3.77
Book Value	30.3	7.83	32.76	36.38	66.48	73.55
Book Value Per Share	0.97	0.25	1.09	1.37	2.75	3.58
Tangible Book Value	30.3	7.83	32.76	36.38	66.48	73.55
Tangible Book Value Per Share	0.97	0.25	1.09	1.37	2.75	3.58

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 7, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 8, 2026

Data Sources Report a data error